Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2010; 16(43): 5518-5522
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5518
Published online Nov 21, 2010. doi: 10.3748/wjg.v16.i43.5518
Figure 1 Serum α-fetoprotein level measured as related to the treatment history.
Serum α-fetoprotein (AFP) level was trending up after sorafenib therapy but normalized after sirolimus was initiated. Events are outlined in the Figure. CT: Computed tomography; HCC: Hepatocellular carcinoma.
Figure 2 Computed tomographys of chest at different time points of the treatment.
The lung lesions were increased in size after sorafenib therapy but significantly reduced in size after sirolimus was introduced in combination with sorafenib. The dates were August 6, 2008 (A), January 26, 2009 (B) and August 26, 2009 (C).
- Citation: Wang Y, Speeg KV, Washburn WK, Halff G. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report. World J Gastroenterol 2010; 16(43): 5518-5522
- URL: https://www.wjgnet.com/1007-9327/full/v16/i43/5518.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i43.5518